Research ArticleDISEASES AND DISORDERS

Activation of P-TEFb by cAMP-PKA signaling in autosomal dominant polycystic kidney disease

See allHide authors and affiliations

Science Advances  05 Jun 2019:
Vol. 5, no. 6, eaaw3593
DOI: 10.1126/sciadv.aaw3593

Article Information

vol. 5 no. 6

Online ISSN: 
History: 
  • Received for publication December 15, 2018
  • Accepted for publication May 2, 2019
  • .

Author Information

  1. Yongzhan Sun1,*,
  2. Zhiheng Liu1,*,
  3. Xinyi Cao1,*,
  4. Yi Lu1,
  5. Zeyun Mi1,
  6. Chaoran He1,
  7. Jing Liu1,
  8. Zhanye Zheng2,
  9. Mulin Jun Li2,
  10. Tiegang Li3,
  11. Dechao Xu4,
  12. Ming Wu5,
  13. Ying Cao6,
  14. Yuhao Li7,
  15. Baoxue Yang8,
  16. Changlin Mei4,,
  17. Lirong Zhang1, and
  18. Yupeng Chen1,9,
  1. 12011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
  2. 22011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Department of Pharmacology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
  3. 3Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
  4. 4Kidney Institute, Department of Nephrology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai 200003, China.
  5. 5Department of Nephrology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, TCM Institute of Kidney Disease of Shanghai University of Traditional Chinese Medicine, Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai 201203, China.
  6. 6Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.
  7. 7Department of Pathology, Nankai University School of Medicine, 94 Weijin Road, Tianjin 300071, China.
  8. 8Department of Pharmacology, School of Basic Medical Sciences, Peking University, Beijing 100038, China.
  9. 9Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, Oncology Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center of Cancer, Tianjin 300060, China.
  1. Corresponding author. Email: chlmei1954{at}126.com (C.M.); lzhang{at}tmu.edu.cn (L.Z.); ychen{at}tmu.edu.cn (Y.C.)
  • * These authors contributed equally to this work.

Altmetric

Article usage

Article usage: June 2019 to September 2020

AbstractFullPdf
Jun 20191632338407
Jul 201926239104
Aug 20191315557
Sep 20191618147
Oct 20191016256
Nov 20191016649
Dec 2019920335
Jan 2020712331
Feb 20201010637
Mar 20201110545
Apr 202089365
May 2020812353
Jun 20201010162
Jul 202027027
Aug 2020211147
Sep 202014533

Stay Connected to Science Advances

Navigate This Article